BioNTech has lifted its revenue forecast for its blockbuster coronavirus vaccine to €17bn this year as demand for the jab continues to grow.
BioNTech將其暢銷新冠疫苗今年全年的營收預測上調至170億歐元。目前全球對這款疫苗的需求持續增長。
您已閱讀6%(192字),剩余94%(3164字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。